Ying Cui

Dr. Ying Cui


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2023
Verified
Other
Open access
LZLixing Zhang
Lixing Zhang
HSHefen Sun
Hefen Sun
FZFangyu Zhao
Fangyu Zhao
PLPing Lu
Ping Lu
CGChao Ge
Chao Ge
JLJinjun Li
Jinjun Li
PDF file - 639K, Supplementary Figure 1. CD133 is CSCs surface marker in PLC/PRF/5 cell line. Supplementary Figure 2. BMP4 showed pro-differentiation effect on HCC cell lines. Supplementary Figure 3. Tumorigenicity of CD133+/- HCC cells co-injected with BMP4 or vehicle embedding beads. Supplementary Figure 4. Canonical BMP4 signaling pathway switches on after exogenous BMP4 treatment. Supplementary Figure 5. BMP4 and SMAD6 expression in HCC cell lines. Supplementary Figure 6. Differentiated CSCs displayed enhanced Erk1/2 phosphorylation.

23 October 2024 in Eye
Verified
Journal Article
Closed access
PDF file
LXLei Xi
Lei Xi
MCMingsi Chi
Mingsi Chi
SYSu Yao
Su Yao
YCYing Cui
Ying Cui

30 March 2023
Verified
Other
Open access
LZLixing Zhang
Lixing Zhang
HSHefen Sun
Hefen Sun
FZFangyu Zhao
Fangyu Zhao
PLPing Lu
Ping Lu
CGChao Ge
Chao Ge
JLJinjun Li
Jinjun Li
PDF file - 639K, Supplementary Figure 1. CD133 is CSCs surface marker in PLC/PRF/5 cell line. Supplementary Figure 2. BMP4 showed pro-differentiation effect on HCC cell lines. Supplementary Figure 3. Tumorigenicity of CD133+/- HCC cells co-injected with BMP4 or vehicle embedding beads. Supplementary Figure 4. Canonical BMP4 signaling pathway switches on after exogenous BMP4 treatment. Supplementary Figure 5. BMP4 and SMAD6 expression in HCC cell lines. Supplementary Figure 6. Differentiated CSCs displayed enhanced Erk1/2 phosphorylation.

11 August 2026 in Current Eye Research
Verified
Journal Article
Closed access
TGTai Guo
Tai Guo
YLYue Liu
Yue Liu
MHMengxia He
Mengxia He
YLYuling Lian
Yuling Lian
XWXiyu Wu
Xiyu Wu
YCYing Cui
Ying Cui
Diabetic retinopathy (DR) is the leading cause of preventable vision impairment among working-age adults.1 Its pathogenesis is multifactorial, characterized by retinal neurodegeneration and microva...

1 January 2026 in Visual Neuroscience
Verified
Journal Article
Open access
PDF file
YLYuman Li
Yuman Li
ZMZhixin Mo
Zhixin Mo
XHXiaofeng Huang
Xiaofeng Huang
MCMingsi Chi
Mingsi Chi
TGTai Guo
Tai Guo
YCYing Cui
Ying Cui
Proliferative diabetic retinopathy (PDR) is the most vision-threatening stage of diabetic retinopathy (DR), a condition increasingly recognized as a neurovascular disorder in which dysregulation of the methionine cycle may impair the retinal neurovascular unit. In this retrospective observational study, targeted metabolomic profiling of the aqueous humor (AH) was performed in 40 eyes from 34 participants categorized into four groups: non-diabetic control individuals; (2) patients without DR; (3) patients with non-proliferative diabetic retinopathy (NPDR); and (4) patients with PDR. Eyes with PDR exhibited markedly elevated homocysteine (fold change 2.31, p < 0.05 vs. controls, with age and diabetes duration acknowledged as potential confounders, given the younger age and longer disease duration in the PDR group) and significantly reduced betaine (fold change 0.61, p < 0.05 vs. NPDR) levels, indicating disruption of the methionine cycle at the neovascular stage. To establish the biological relevance of these findings in AH, in vitro experiments in high-glucose-stimulated human retinal microvascular endothelial cells were performed, which demonstrated that betaine (1,000 μM) significantly suppressed endothelial proliferation, migration, and tube formation (p < 0.01 for proliferation and migration; p < 0.05 for tube formation) compared with high-glucose controls—providing a mechanistic link between the observed aqueous betaine depletion and pathological retinal angiogenesis. In an exploratory subset evaluated with widefield swept-source optical coherence tomography angiography (WF SS-OCTA; 12 eyes from 9 patients), betaine levels were found to be positively correlated with deep vascular complex density (r = 0.734, p = 0.007) and fractal dimension (r = 0.657, p = 0.020), while homocysteine was found to be negatively correlated with superficial vascular parameters (r = −0.623, p = 0.030), suggesting that methionine-cycle imbalance may reflect a broader neurovascular dysfunction. These findings position betaine as a candidate metabolic indicator warranting further investigation in PDR.

30 March 2023
Verified
Other
Open access
LZLixing Zhang
Lixing Zhang
HSHefen Sun
Hefen Sun
FZFangyu Zhao
Fangyu Zhao
PLPing Lu
Ping Lu
CGChao Ge
Chao Ge
JLJinjun Li
Jinjun Li
CD133+ cancer stem cells (CSC) contribute to hepatocellular carcinoma (HCC) progression and resistance to therapy. Bone morphogenetic protein BMP4 plays an important role in hepatogenesis and hepatic stem cell differentiation, but little is known about its function in hepatic CSCs. In this study, we showed that high-dose exogenous BMP4 promotes CD133+ HCC CSC differentiation and inhibits the self-renewal, chemotherapeutic resistance, and tumorigenic capacity of these cells. Interestingly, we found that low-dose exogenous BMP4 upregulated CD133 protein expression in vitro, and endogenous BMP4 was preferentially expressed in CD133+ HCC CSCs, suggesting that low doses of BMP4 may facilitate CSC maintenance. A reduction in endogenous BMP4 levels decreased CD133 protein expression in vitro. In HCC tissues, expression of the BMP4 signaling target gene SMAD6 was positively correlated with CD133 expression. Activation of the Erk1/2 signaling pathway led to BMP4-mediated reduction in CD133 expression, which was reversed by treatment with MEK inhibitors. Taken together, our findings indicated that BMP4 might be a potent therapeutic agent in HCC that targets CSCs. Cancer Res; 72(16); 4276–85. ©2012 AACR.